Micron Biomedical was ranked second on Fast Company's 2026 list of the World's Most Innovative Smaller Companies for its dissolvable, needle-free vaccine and drug delivery technology. This innovation addresses major barriers like needle phobia, clinician shortages, and cold chain logistics, improving access to vaccines and treatments globally. The technology allows painless, self-administered doses that simplify manufacturing, storage, and transport, with ongoing clinical trials supported by the CDC. Micron's approach is recognized as a global priority for expanding immunization in low- and middle-income countries, with further data to be presented at the 2026 World Vaccine Congress.
The global automotive microcontrollers market is projected to grow from USD 15.49 billion in 2025 to USD 34.31 billion by 2035, at a CAGR of 8.28%. Growth is fueled by increasing adoption of advanced driver-assistance systems (ADAS), vehicle electrif...
Garmin introduced the G2000 PRIME, a new integrated flight deck designed for high-performance Class I/II piston and electric aircraft. It features large, edge-to-edge touchscreen displays with advanced multi-touch capabilities, faster processors, and...
UniFirst Corporation has been recognized on Selling Power's 60 Best Companies to Sell For list for the 23rd consecutive year, highlighting its strong sales culture and support for sales professionals. The list evaluates companies on compensation, tra...
The global Reactive Hot Melt Adhesives market is projected to grow from USD 2.02 billion in 2025 to USD 4.29 billion by 2035, at a CAGR of 7.72%. Growth is fueled by regulations limiting solvent adhesives, increased use of polyurethane adhesives in a...
Montero Mining completed drillhole MON-ELV-02 to 625.25 meters at its Elvira Gold Project in Chile, successfully testing its top exploration target. The hole confirmed predicted volcanic and porphyry sequences with extensive pyrite and high-sulphidat...
